Error: Could not add to watchlist. X

Retrophin Inc

+ Watchlist
DGTE:US
Ticker Change
DGTE:US has changed to a new ticker symbol
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Retrophin, Inc. is a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. The Company is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases.
ADDRESS
777 Third Avenue
22nd Floor
New York, NY 10017
United States
PHONE
1-646-837-5863
  • Stephen J Aselage "Steve"
    President/CEO
  • Horacio Plotkin
    Chief Medical Officer
  • Alvin Shih
    Exec VP:Research & Development
  • Laura M Clague
    Senior VP/CFO
  • Margaret E Valeur-Jensen
    General Counsel
Show More